Cerebrolysin vs Synapsin
A side-by-side research comparison of Cerebrolysin and Synapsin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Cerebrolysin | Synapsin |
|---|---|---|
| Full name | Cerebrolysin (Brain-Derived Peptide Preparation) | Synapsin Nasal Spray (RG3 + NAD+ + Methylcobalamin) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Investigational | Compounded medication |
| Mechanism | Contains fragments mimicking NGF, BDNF, GDNF, CNTF. Enhances synaptic plasticity, promotes neuronal sprouting, reduces amyloid-beta, and stabilizes calcium homeostasis. | Rg3 reduces neuroinflammation and protects neurons. NAD+ supports mitochondrial function and sirtuin activation in brain cells. Methylcobalamin provides methylation support and myelin repair. Nasal route bypasses BBB for direct CNS delivery. |
| Molecular weight | <10,000 Da (peptide fraction) | Combination compound |
| Half-life | 4-6 hours | Variable (nasal depot effect) |
| Bioavailability | High (IM/IV) | ~60-80% nasal (direct CNS access) |
| Typical dose | 5-30 mL | 1-2 sprays per nostril |
| Frequency | Daily for 10-20 days | 1-2x daily |
| Route | Intramuscular or IV | Intranasal spray |
Cerebrolysin reported benefits
- Neurotrophic support
- Stroke recovery
- Memory improvement
- Neuroprotection
- Synaptic plasticity
- Approved in 40+ countries
Synapsin reported benefits
- Improved mental clarity
- Reduced brain fog
- Neuroprotection
- Enhanced focus
- Nerve repair support
- Anti-neuroinflammatory
Related comparisons
Research and educational reference only. Not medical advice.